Literature DB >> 6325501

Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites.

S J Weiss, S Regiani.   

Abstract

Triggered neutrophils rapidly degraded labeled matrices secreted by cultured, venous endothelial cells via a process dependent on elastase but not oxygen metabolites. In the presence of high concentrations of alpha-1-proteinase inhibitor, the ability of the stimulated neutrophil to solubilize the matrix was impaired. However, at lower concentrations of alpha-1-proteinase inhibitor the neutrophil could enhance the degradative potential of its released elastase by a H2O2-dependent process. Coincident with this increase in matrix damage, the stimulated neutrophil destroyed the elastase inhibitory activity of the alpha-1-proteinase inhibitor via a catalase-inhibitable process. The ability of the triggered neutrophil to solubilize the matrix in the presence of alpha-1-proteinase inhibitor was unaffected by superoxide dismutase or hydroxyl radical scavengers but was markedly impaired by catalase, azide, or hypochlorous acid scavengers. We conclude that neutrophils can cooperatively use an oxidant with characteristics similar, if not identical, to hypochlorous acid and the lysosomal proteinase elastase to negate the protective effects of alpha-1-proteinase inhibitor in order to attack the subendothelial matrix.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325501      PMCID: PMC425151          DOI: 10.1172/JCI111332

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  The effects in vivo and in vitro of oxidative damage to purified alpha1-antitrypsin and to the enzyme-inhibiting activity of plasma.

Authors:  A B Cohen
Journal:  Am Rev Respir Dis       Date:  1979-06

2.  The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness.

Authors:  E L Becker; H J Showell; P M Henson; L S Hsu
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

3.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Human neutrophil elastase functions as a type III collagen "collagenase".

Authors:  J E Gadek; G A Fells; D G Wright; R G Crystal
Journal:  Biochem Biophys Res Commun       Date:  1980-08-29       Impact factor: 3.575

6.  In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.

Authors:  H Carp; A Janoff
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

7.  Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments.

Authors:  J A McDonald; D G Kelley
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

8.  Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.

Authors:  H Carp; A Janoff
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.

Authors:  K Beatty; J Bieth; J Travis
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

10.  Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules.

Authors:  C L Mainardi; S N Dixit; A H Kang
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

View more
  58 in total

Review 1.  Myeloperoxidase production by macrophage and risk of atherosclerosis.

Authors:  Mahir Karakas; Wolfgang Koenig
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 2.  The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema.

Authors:  J E Gadek; E R Pacht
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Mechanism of prostaglandin E2 inhibition of acute changes in vascular permeability.

Authors:  K R McLeish; S R Wellhausen; G T Stelzer
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

4.  Inhibition of myeloperoxidase by synovial fluid and serum.

Authors:  B Dularay; C M Yea; C J Elson
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

5.  Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization.

Authors:  Melissa van Pel; Ronald van Os; Gerjo A Velders; Henny Hagoort; Peter M H Heegaard; Ivan J D Lindley; Roel Willemze; Willem E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

6.  Chemiluminescence of neutrophils in patients with glomerulonephritis treated with methylprednisolone.

Authors:  J Kuźniar; W Sajewicz; W Kopeć; Z Hruby
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

7.  Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures.

Authors:  Klaus Dinkel; Firdaus S Dhabhar; Robert M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-18       Impact factor: 11.205

8.  Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.

Authors:  M Shingu; K Yoshioka; M Nobunaga; K Yoshida
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

9.  Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells.

Authors:  E Carrasco-Marín; J E Paz-Miguel; P López-Mato; C Alvarez-Domínguez; F Leyva-Cobián
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

10.  Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor.

Authors:  J I Weitz; E K Silverman; B Thong; E J Campbell
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.